» Articles » PMID: 28122966

Osmotic Stress-Induced Defective Glial Proteostasis Contributes to Brain Demyelination After Hyponatremia Treatment

Overview
Specialty Nephrology
Date 2017 Jan 27
PMID 28122966
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Adequate protein folding is necessary for normal cell function and a tightly regulated process that requires proper intracellular ionic strength. In many cell types, imbalance between protein synthesis and degradation can induce endoplasmic reticulum (ER) stress, which if sustained, can in turn lead to cell death. In nematodes, osmotic stress induces massive protein aggregation coupled with unfolded protein response and ER stress. In clinical practice, patients sustaining rapid correction of chronic hyponatremia are at risk of osmotic demyelination syndrome. The intense osmotic stress sustained by brain cells is believed to be the major risk factor for demyelination resulting from astrocyte death, which leads to microglial activation, blood-brain barrier opening, and later, myelin damage. Here, using a rat model of osmotic demyelination, we showed that rapid correction of chronic hyponatremia induces severe alterations in proteostasis characterized by diffuse protein aggregation and ubiquitination. Abrupt correction of hyponatremia resulted in vigorous activation of both the unfolded protein response and ER stress accompanied by increased autophagic activity and apoptosis. Immunofluorescence revealed that most of these processes occurred in astrocytes within regions previously shown to be demyelinated in later stages of this syndrome. These results identify osmotic stress as a potent protein aggregation stimuli in mammalian brain and further suggest that osmotic demyelination might be a consequence of proteostasis failure on severe osmotic stress.

Citing Articles

Thalamic Neuron Resilience during Osmotic Demyelination Syndrome (ODS) Is Revealed by Primary Cilium Outgrowth and ADP-ribosylation factor-like protein 13B Labeling in Axon Initial Segment.

Gilloteaux J, De Swert K, Suain V, Nicaise C Int J Mol Sci. 2023; 24(22).

PMID: 38003639 PMC: 10671465. DOI: 10.3390/ijms242216448.


The ubiquitin codes in cellular stress responses.

Sheng X, Xia Z, Yang H, Hu R Protein Cell. 2023; 15(3):157-190.

PMID: 37470788 PMC: 10903993. DOI: 10.1093/procel/pwad045.


Treatment Guidelines for Hyponatremia: Stay the Course.

Sterns R, Rondon-Berrios H, Adrogue H, Berl T, Burst V, Cohen D Clin J Am Soc Nephrol. 2023; 19(1):129-135.

PMID: 37379081 PMC: 10843202. DOI: 10.2215/CJN.0000000000000244.


Adaptation of the Brain to Hyponatremia and Its Clinical Implications.

Gankam Kengne F J Clin Med. 2023; 12(5).

PMID: 36902500 PMC: 10002753. DOI: 10.3390/jcm12051714.


The Blood-Brain Barrier-A Key Player in Multiple Sclerosis Disease Mechanisms.

Schreiner T, Romanescu C, Popescu B Biomolecules. 2022; 12(4).

PMID: 35454127 PMC: 9025898. DOI: 10.3390/biom12040538.


References
1.
Hetz C, Chevet E, Oakes S . Proteostasis control by the unfolded protein response. Nat Cell Biol. 2015; 17(7):829-38. PMC: 5546321. DOI: 10.1038/ncb3184. View

2.
Gocht A, Lohler J . Changes in glial cell markers in recent and old demyelinated lesions in central pontine myelinolysis. Acta Neuropathol. 1990; 80(1):46-58. DOI: 10.1007/BF00294221. View

3.
Lecker S, Goldberg A, Mitch W . Protein degradation by the ubiquitin-proteasome pathway in normal and disease states. J Am Soc Nephrol. 2006; 17(7):1807-19. DOI: 10.1681/ASN.2006010083. View

4.
Sterns R, Riggs J, SCHOCHET Jr S . Osmotic demyelination syndrome following correction of hyponatremia. N Engl J Med. 1986; 314(24):1535-42. DOI: 10.1056/NEJM198606123142402. View

5.
Szegezdi E, Logue S, Gorman A, Samali A . Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep. 2006; 7(9):880-5. PMC: 1559676. DOI: 10.1038/sj.embor.7400779. View